Note: Names and details are provided for your information only. Decisions regarding choice of surgeon and treatment options are a patient's responsibility, as is all communication and interaction with listed medical professionals. Any information you send to a surgeon is not covered by our Privacy Policy.
Learn how the LAP-BAND® System can provide significant weight loss with no amputation, stapling of the stomach, or cutting of the intestines.1,3
Take a closer look at the differences and similarities between sleeve gastrectomy and the LAP-BAND® System.
*The Bariatric Outcomes Longitudinal Database™ (BOLD™) was developed to help ensure ongoing compliance with the American Society for Metabolic and Bariatric Surgery (ASMBS) Bariatric Surgery Center of Excellence (BSCOE) program and develop general knowledge about optimal bariatric surgery practices. This analysis of the BOLD™ database includes data from 57,918 patients.
†The American College of Surgeons Bariatric Surgery Center Network (ACS-BSCN) database was developed as part of the ACS-BSCN accreditation program. This analysis of the ACS database includes data from 28,616 patients.
Indications: The LAP-BAND® System is indicated for weight reduction for patients with obesity, with a Body Mass Index (BMI) of at least 40 kg/m2 or a BMI of at least 30 kg/m2 with one or more obesity-related comorbid conditions.
It is indicated for use only in adult patients who have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives.
Contraindications: The LAP-BAND® System is not recommended for non-adult patients, patients with conditions that may make them poor surgical candidates or increase the risk of poor results (e.g., inflammatory or cardiopulmonary diseases, GI conditions, symptoms or family history of autoimmune disease, cirrhosis), who are unwilling or unable to comply with the required dietary restrictions, who have alcohol or drug addictions, or who currently are or may be pregnant.
Warnings: The LAP-BAND® System is a long-term implant. Explant and replacement surgery may be required. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.
Adverse Events: Placement of the LAP-BAND® System is major surgery and, as with any surgery, death can occur. Possible complications include the risks associated with the medications and methods used during surgery, the risks associated with any surgical procedure, and the patient's ability to tolerate a foreign object implanted in the body.
Band slippage, erosion and deflation, reflux, obstruction of the stomach, dilation of the esophagus, infection, or nausea and vomiting may occur. Reoperation may be required.
Rapid weight loss may result in complications that may require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or esophageal dilation.
Important: For full safety information please visit www.lapband.com, talk with your doctor, or call Allergan Product Support at 1-800-624-4261.
CAUTION: Rx only.
© 2013 Allergan, Inc., Irvine CA 92612, U.S.A. ® and ™ Marks Owned by Allergan, Inc. All rights reserved. Any third-party trademarks used herein are the property of their respective owners. This site is intended for U.S. residents only. APC56BL13
For Bariatric Specialists
www.lapbandcentral.com
For Other Healthcare Professionals
www.lapbandHCP.com